Difficulties in diagnosis and treatment of Paget's disease

被引:0
|
作者
Kawalec, Aleksandra [1 ]
Zdrojowy-Welna, Aleksandra [2 ]
Bednarek-Tupikowska, Grazyna [2 ]
机构
[1] Salmed Specialized Clin Swiebodzice, Swiebodzice, Poland
[2] Med Univ Wroclaw, Clin Endocrinol Diabetol & Isotope Therapy, Independent Publ Teaching Hosp Wroclaw 1, Wroclaw, Poland
来源
FAMILY MEDICINE AND PRIMARY CARE REVIEW | 2016年 / 18卷 / 04期
关键词
Paget's disease; alkaline phosphatase; bisphosphonates;
D O I
10.5114/fmpcr.2016.63712
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Paget's disease is a rare finding in Poland. It is a disorder of the osteoarticular system, which, in adults, mostly affects people over 55 years of age. The clinical picture varies, depending on the location of the lesions, making the diagnosis difficult, sometimes taking many years for a correct diagnosis to be made. In etiopathogenesis, genetic predispositions as well as viral infections play an important role. From the genetic point of view, Paget's disease is heterogeneous, as numerous mutations are known, and the genotype to phenotype relationship is unclear. The first phase of the disease is characterized by an increased osteolytic activity, due to morphologically changed and RANKL overstimulated osteocytes. This leads to an intensification of ossification processes that occur in a chaotic manner. Therefore, the resulting bone is weak, extensively vascularized and there is an increased risk of fracture or deformity. Clinical manifestations of Paget's disease might include pain, excessive warmth, bone deformations, degenerative lesions in the adjacent joints, compression of the neural structures, hearing loss, and dilated cardiomiopathy. Other possible complications include the development of benign and malignant bone tumors and hypercalcaemia in the case of immobilization. An elevated level of serum alkaline phosphatase, bone x-ray and bone scintigraphy are crucial in making the diagnosis. The disease should be distinguished from osteomalacia, osteoporosis, hyperparathyroidism and multiple myeloma. Bisphosphonates at doses higher than those applied for osteoporosis are an effective treatment. The occurrence of orthopedic, neurological and laryngological complications is often a reason for surgical intervention.
引用
收藏
页码:501 / 505
页数:5
相关论文
共 50 条
  • [31] Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline
    Ralston, Stuart H.
    Corral-Gudino, Luis
    Cooper, Cyrus
    Francis, Roger M.
    Fraser, William D.
    Gennari, Luigi
    Guanabens, Nuria
    Javaid, M. Kassim
    Layfield, Robert
    O'Neill, Terence W.
    Russell, R. Graham G.
    Stone, Michael D.
    Simpson, Keith
    Wilkinson, Diana
    Wills, Ruth
    Zillikens, M. Carola
    Tuck, Stephen P.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 (04) : 579 - 604
  • [32] Emerging strategies and therapies for treatment of Paget's disease of bone
    Michou, Laetitia
    Brown, Jacques P.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2011, 5 : 225 - 239
  • [33] Medical management of Paget's disease of bone: Indications for treatment and review of current therapies
    Siris, Ethel S.
    Lyles, Kenneth W.
    Singer, Frederick R.
    Meunier, Pierce J.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : P94 - P98
  • [34] Bisphosphonate space measurement and dosage requirement for intravenous clodronate treatment of Paget's disease
    Rutland, M
    Wattie, D
    Que, L
    Hassan, IM
    Cundy, T
    CALCIFIED TISSUE INTERNATIONAL, 2002, 70 (02) : 99 - 102
  • [35] Surgical treatment in spine Paget’s disease: a systematic review
    Jorge-Mora A.
    Amhaz-Escanlar S.
    Lois-Iglesias A.
    Leborans-Eiris S.
    Pino-Minguez J.
    European Journal of Orthopaedic Surgery & Traumatology, 2016, 26 (1) : 27 - 30
  • [36] The Use of Intravenous Aminobisphosphonates for the Treatment of Paget's Disease of Bone
    Gennari, Luigi
    Merlotti, Daniela
    Mossetti, Giuseppe
    Rendina, Domenico
    De Paola, Vincenzo
    Martini, Giuseppe
    Nuti, Ranuccio
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2009, 9 (09) : 1052 - 1063
  • [37] Current perspectives on bisphosphonate treatment in Paget's disease of bone
    Wat, Winnie Zee Man
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 977 - 983
  • [38] Is the prevalence of Paget's disease of bone decreasing?
    Cundy, Tim
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : P9 - P13
  • [39] Skeletal dissemination in Paget's disease of the spine
    Rolvien, Tim
    Butscheidt, Sebastian
    Zustin, Jozef
    Amling, Michael
    EUROPEAN SPINE JOURNAL, 2018, 27 : S453 - S457
  • [40] Skeletal dissemination in Paget’s disease of the spine
    Tim Rolvien
    Sebastian Butscheidt
    Jozef Zustin
    Michael Amling
    European Spine Journal, 2018, 27 : 453 - 457